Keywords: Novo Nordisk, Scotland, Victoza, Diabetes

Scottish Medical Consortium backs use of Novo Nordisk’s Victoza for type 2 diabetics

Article | 09 December 2009

Print This

Following marketing approval by the European Commission and the subsequent UK launch on July 7, 2009 of Novo Nordisk’s Victoza (liraglutide), ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in